BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 21729665)

  • 21. Extra copies of ALK gene locus is a recurrent genetic aberration and favorable prognostic factor in both ALK-positive and ALK-negative anaplastic large cell lymphomas.
    Yu R; Chen G; Zhou C; Gao Z; Shi Y; Shi Y; Zhou X; Xie J; Liu H; Gong L
    Leuk Res; 2012 Sep; 36(9):1141-6. PubMed ID: 22726922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A small cell variant of ALK-positive, CD8-positive anaplastic large cell lymphoma with primary subcutaneous presentation mimicking subcutaneous panniculitis-like T-cell lymphoma.
    Wang E; Papalas J; Siddiqi I; Stoecker M; Rehder C; Sebastain S; Burchette J; Huang Q
    Pathol Res Pract; 2011 Aug; 207(8):522-6. PubMed ID: 21763080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatal ALK-negative systemic anaplastic large cell lymphoma presenting with disseminated cutaneous dome-shaped papules and nodules.
    Bird JE; Leitenberger JJ; Solomon A; Blauvelt A; Hopkins S
    Dermatol Online J; 2012 May; 18(5):5. PubMed ID: 22630575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extranodal NK/T-cell lymphoma, nasal type, arising in association with saline breast implant: expanding the spectrum of breast implant-associated lymphomas.
    Aladily TN; Nathwani BN; Miranda RN; Kansal R; Yin CC; Protzel R; Takowsky GS; Medeiros LJ
    Am J Surg Pathol; 2012 Nov; 36(11):1729-34. PubMed ID: 23073330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast implant-associated anaplastic large cell lymphoma - From diagnosis to treatment.
    Kaartinen I; Sunela K; Alanko J; Hukkinen K; Karjalainen-Lindsberg ML; Svarvar C
    Eur J Surg Oncol; 2017 Aug; 43(8):1385-1392. PubMed ID: 28625797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anaplastic large cell lymphoma of the breast arising around mammary implant capsule: an Italian report.
    Farace F; Bulla A; Marongiu F; Campus GV; Tanda F; Lissia A; Cossu A; Fozza C; Rubino C
    Aesthetic Plast Surg; 2013 Jun; 37(3):567-71. PubMed ID: 23620008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary ALK-1-negative anaplastic large cell lymphoma of the brain: case report and review of the literature.
    Kodama K; Hokama M; Kawaguchi K; Tanaka Y; Hongo K
    Neuropathology; 2009 Apr; 29(2):166-71. PubMed ID: 18564100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent PDL1 expression and PDL1 (CD274) copy number alterations in breast implant-associated anaplastic large cell lymphomas.
    Tabanelli V; Corsini C; Fiori S; Agostinelli C; Calleri A; Orecchioni S; Melle F; Motta G; Rotili A; Di Napoli A; Pileri SA
    Hum Pathol; 2019 Aug; 90():60-69. PubMed ID: 31125630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination.
    ten Berge RL; Oudejans JJ; Ossenkoppele GJ; Pulford K; Willemze R; Falini B; Chott A; Meijer CJ
    J Clin Pathol; 2000 Jun; 53(6):445-50. PubMed ID: 10911802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of putative pathogenic microRNA and its downstream targets in anaplastic lymphoma kinase-negative anaplastic large cell lymphoma.
    Mehrotra M; Medeiros LJ; Luthra R; Sargent RL; Yao H; Barkoh BA; Singh R; Patel KP
    Hum Pathol; 2014 Oct; 45(10):1995-2005. PubMed ID: 25128227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implant-associated anaplastic large cell lymphoma: beyond breast prostheses.
    Kellogg BC; Hiro ME; Payne WG
    Ann Plast Surg; 2014 Oct; 73(4):461-4. PubMed ID: 23722577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anaplastic Large Cell Lymphoma: Contemporary Concepts and Optimal Management.
    Shustov A; Soma L
    Cancer Treat Res; 2019; 176():127-144. PubMed ID: 30596216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromosome 20 loss is characteristic of breast implant-associated anaplastic large cell lymphoma.
    Los-de Vries GT; de Boer M; van Dijk E; Stathi P; Hijmering NJ; Roemer MGM; Mendeville M; Miedema DM; de Boer JP; Rakhorst HA; van Leeuwen FE; van der Hulst RRWJ; Ylstra B; de Jong D
    Blood; 2020 Dec; 136(25):2927-2932. PubMed ID: 33331925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast Implant and Anaplastic Large Cell Lymphoma Meta-Analysis.
    Ramos-Gallardo G; Cuenca-Pardo J; Rodríguez-Olivares E; Iribarren-Moreno R; Contreras-Bulnes L; Vallarta-Rodríguez A; Kalixto-Sanchez M; Hernández C; Ceja-Martinez R; Torres-Rivero C
    J Invest Surg; 2017 Feb; 30(1):56-65. PubMed ID: 27537783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Highly aggressive ALK-positive anaplastic large cell lymphoma with a leukemic phase and multi-organ involvement: a report of three cases and a review of the literature.
    Grewal JS; Smith LB; Winegarden JD; Krauss JC; Tworek JA; Schnitzer B
    Ann Hematol; 2007 Jul; 86(7):499-508. PubMed ID: 17396261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary cutaneous ALCL with phosphorylated/activated cytoplasmic ALK and novel phenotype: EMA/MUC1+, cutaneous lymphocyte antigen negative.
    Kadin ME; Pinkus JL; Pinkus GS; Duran IH; Fuller CE; Onciu M; Kawaguchi H; Morris SW
    Am J Surg Pathol; 2008 Sep; 32(9):1421-6. PubMed ID: 18670345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Story of survival in anaplastic large cell lymphoma - sometimes more than the anaplastic lymphoma kinase status: An evaluation of pathologic prognostic factors in 102 cases.
    Agrawal K; Shet T; Sridhar E; Dhende S; Sengar M; Arora B; Laskar S; Gujral S; Menon H; Banavali S
    Indian J Pathol Microbiol; 2017; 60(4):533-540. PubMed ID: 29323068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anaplastic large cell lymphoma: one or more entities among T-cell lymphoma?
    Fornari A; Piva R; Chiarle R; Novero D; Inghirami G
    Hematol Oncol; 2009 Dec; 27(4):161-70. PubMed ID: 19358142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ALK-negative anaplastic large cell lymphoma with extensive peripheral blood and bone marrow involvements manifested as "leukemic phase".
    Lu Y; Zhao X; Wang E; Chen W; Huang Q
    Leuk Res; 2010 Apr; 34(4):475-82. PubMed ID: 19695703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of fascin expression in anaplastic large cell lymphoma and Hodgkin disease.
    Fan G; Kotylo P; Neiman RS; Braziel RM
    Am J Clin Pathol; 2003 Feb; 119(2):199-204. PubMed ID: 12579989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.